Presence of Keap1 and p62 double-positive aggregates in human liver diseases.
| Pathological diagnosis | Total number | p62 and Keap1 double-positive lesions | Percentage |
| Normal | 12 | 0 | 0.0 |
| Cellular hypertrophy | 2 | 0 | 0.0 |
| Hepatitis | 13 | 1 | 7.7 |
| Cirrhosis | 40 | 3 | 7.5 |
| Hepatocellular carcinoma | 102 | 26 | 25.5 |
| Tissue adjacent to hepatocellular carcinoma | 61 | 13 | 21.3 |
| Non-HCC tumor | 14 | 1 | 7.1 |
| Clear cell carcinoma | 5 | 0 | – |
| Bile duct carcinoma | 4 | 1 | – |
| Metastasis adenoma | 3 | 0 | – |
| Sarcoma | 1 | 0 | – |
| Hemangioma | 1 | 0 | – |
| Pathological diagnosis | Total number | p62 and Keap1 double-positive lesions | Percentage |
| Normal | 12 | 0 | 0.0 |
| Cellular hypertrophy | 2 | 0 | 0.0 |
| Hepatitis | 13 | 1 | 7.7 |
| Cirrhosis | 40 | 3 | 7.5 |
| Hepatocellular carcinoma | 102 | 26 | 25.5 |
| Tissue adjacent to hepatocellular carcinoma | 61 | 13 | 21.3 |
| Non-HCC tumor | 14 | 1 | 7.1 |
| Clear cell carcinoma | 5 | 0 | – |
| Bile duct carcinoma | 4 | 1 | – |
| Metastasis adenoma | 3 | 0 | – |
| Sarcoma | 1 | 0 | – |
| Hemangioma | 1 | 0 | – |